5 hours Insulet (NASDAQ:PODD) Price Target Raised to $275.00 at Citigroup MarketBeat
Citigroup boosted their price target on shares of Insulet from $250.00 to $275.00 and gave the stock a “buy” rating in a research note on Tuesday.
Citigroup (C) · Nasdaq 100 · Science